Global Research on Ophthalmic Drugs - Analysis, Size, Share, Trends, and Forecast 2017 - 2025
"Ophthalmic
Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends,
and Forecast 2017 - 2025"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
.
.
Description-
'
'
– – Global
Ophthalmic Drugs Market: Overview – –
Ophthalmic drugs is a growing market driven by
rising prevalence of intraocular eye disorders mainly in elderly
population like glaucoma, cataract, age-related macular degeneration,
diabetic retinopathy, etc. Also, there is an increasing incidence of
eye diseases globally such as dry eye, conjunctivitis, uveitis, and
others, and the number of patients suffering from eye diseases is
expected to grow exponentially during the forecast period. As a
result of this increasing patient pool across the globe, major market
players are increasing R&D investments to capture the significant
commercial opportunity through innovations in treatment methods, and
improvement in drug’s mechanism of action with novel biological
agents.
Get
Sample
Report
@
https://www.researchmoz.us/enquiry.php?type=S&repid=186323
'
'
The
market overview section of the report comprises qualitative analysis
of the overall ophthalmic drugs market considering the factors
determining the market dynamics such as drivers, restraints and
opportunities, along with Porter’s five force analysis and market
attractiveness analysis. In addition, such as market opportunity
analysis for the disease indications, therapeutic class, product
type, and distribution channels, and key industry developments has
also been provided. Key industry developments include the major
events occurred in past decade and are expected to occur during the
forecast period which are likely to affect the market dynamics. The
company share analysis has also been provided for global glaucoma
drug market.
The
pipeline analysis of major as well as emerging market players has
been given in the market overview section, along with the product
comparison matrix of the major market players. The report also
consists of a section depicting the major causes of blindness
globally, as well as by regions.
– – Global
Ophthalmic Drugs Market: Segmentation
– –
The global ophthalmic drugs market is segmented in
terms of disease indication, therapeutic class, product type, and
distribution channels. The disease indication segment is further
classified into dry eye, glaucoma, infection/inflammation, retinal
disorders, allergy, uveitis, and others. The retinal disorders
segment is further classified into wet age-related macular
degeneration, dry age-related macular degeneration, diabetic
retinopathy, and others. Among the disease indication segment, the
retinal disorders segment accounted for the largest share of the
global ophthalmic drugs market in 2016, owing to factors like
exponentially rising patient pool demanding long-term treatment.
However, the dry eye segment is expected to grow at a high CAGR
during the forecast period, due to changing environmental conditions,
pollutions, etc.
In terms of therapeutic class, global ophthalmic
drugs market is divided into anti-inflammatory drugs, anti-infective
drugs, anti-glaucoma drugs, anti-allergy drugs, anti-VEGF agents, and
others. The anti-inflammatory drugs segment is bi-furcated into
nonsteroidal anti-inflammatory drugs, and steroids. The
anti-infective drugs are further sub-segmented into anti-fungal
drugs, anti-bacterial drugs, and others. The anti-glaucoma drugs
segment is classified into alpha agonist, beta blockers,
prostaglandin analogs, combined medication, and others. On the basis
of product type, the market is segmented into prescription drugs and
OTC drugs. Based on distribution channels, the global ophthalmic
drugs market is segmented into hospital pharmacies, online
pharmacies, and independent pharmacies & drug stores.
Geographically, the ophthalmic drugs market has
been categorized into five regions namely: North America, Europe,
Asia-Pacific, Latin America, and the Middle East & Africa. The
market size and forecast for each region has been provided for the
period 2015 to 2025, in terms of disease indication, therapeutic
class, product type, and distribution channels, along with the CAGR
(%) for the forecast period 2017 to 2025.
– – Global
Ophthalmic Drugs Market: Competitive Analysis
– –
The report also provides a section on the
competitive landscape, wherein the market share analysis of leading
players in the global ophthalmic drugs market, in terms of percentage
share in 2016 has been discussed. A list of recommendations has also
been included for new entrants as well as existing market players to
help them establish a strong presence in the market and increase
their market share. The report concludes with the profiles of major
players in the global ophthalmic drugs market such as Aerie
Pharmaceuticals, Inc., ALLERGAN, Valeant Pharmaceuticals
International, Inc., Bayer AG, Genentech, Inc. (F. Hoffmann-La Roche
Ltd.), Novartis AG , Pfizer Inc., Regeneron Pharmaceuticals, Inc.,
Santen Pharmaceutical Co., Ltd., and Shire among others. The major
market players are evaluated on various parameters such as company
overview, financial overview, product portfolio, business strategies
and recent developments.
– – Global
Ophthalmic Drugs Market is segmented as follows:
– –
– Global Ophthalmic
Drugs Market, by Disease Indication
- Dry Eye
- Glaucoma
- Infection/Inflammation
- Retinal Disorders
- Wet Age-related Macular Degeneration
- Dry Age-related Macular Degeneration
- Diabetic Retinopathy
- Others
- Allergy
- Uveitis
- Others
– Global Ophthalmic
Drugs Market, by Therapeutic Class
- Anti-inflammatory Drugs
- Nonsteroidal Anti-inflammatory Drugs
- Steroids
- Anti-infective Drugs
- Anti-fungal Drugs
- Anti-bacterial Drugs
- Others
- Anti-glaucoma Drugs
- Alpha Agonist
- Beta Blockers
- Prostaglandin Analogs
- Combined Medication
- Others
- Anti-allergy Drugs
- Anti-VEGF Agents
- Others
– Global Ophthalmic
Drugs Market, by Product Type
- Prescription Drugs
- Over-the-Counter Drugs
– Global Ophthalmic
Drugs Market, by Distribution Channel
- Hospital Pharmacies
- Online Pharmacies
- Independent Pharmacies & Drug Stores
– Global Ophthalmic
Drugs Market, by Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
.
.
Comments
Post a Comment